Meghmani Organics Ltd Hits All-Time Low Amid Continued Market Pressure

Recent Price Movements and Market Context

On 27 Jan 2026, Meghmani Organics Ltd’s share price declined by 1.09%, underperforming the Sensex which fell by 0.34% on the same day. The stock has been on a losing streak for two consecutive sessions, accumulating a 4.07% loss over this period. This decline has pushed the stock to trade below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum.

Over the past month, the stock has plunged 14.13%, significantly underperforming the Sensex’s 4.44% decline. The three-month performance is even more stark, with a 31.24% drop compared to the Sensex’s 4.15% fall. Year-to-date, Meghmani Organics has lost 14.15%, while the Sensex has declined by 4.65%. The stock’s one-year return stands at -24.91%, in contrast to the Sensex’s positive 7.82% gain. Over three years, the stock has depreciated by 43.91%, whereas the Sensex has appreciated by 36.96%. Notably, the stock has delivered no gains over five and ten-year horizons, while the Sensex has surged 71.40% and 231.78% respectively.

Fundamental Assessment and Ratings

Meghmani Organics currently holds a Mojo Score of 32.0 with a Mojo Grade of Sell, upgraded from a Strong Sell as of 1 Jan 2026. The company’s Market Cap Grade is rated 3, indicating a modest market capitalisation relative to peers. Despite the recent upgrade, the rating reflects ongoing concerns about the company’s financial health and market position.

The company’s long-term fundamentals reveal a compound annual growth rate (CAGR) of -18.02% in operating profits over the last five years, underscoring a contraction in core earnings. Return on Equity (ROE) averages at 6.03%, signalling limited profitability relative to shareholders’ funds. This low ROE suggests that the company has struggled to generate substantial returns on invested capital.

Domestic mutual funds hold no stake in Meghmani Organics, a notable absence given their capacity for detailed company analysis. This lack of institutional interest may reflect reservations about the company’s valuation or business prospects at current price levels.

Comparative Performance and Valuation Metrics

Meghmani Organics has consistently underperformed its benchmark indices, including the BSE500, across the last three annual periods. The stock’s negative returns contrast sharply with the broader market’s positive trajectory, highlighting its relative weakness within the sector.

Despite the subdued price performance, the company has reported positive financial results for five consecutive quarters. Net sales for the latest six-month period reached Rs 1,190.88 crores, reflecting a growth rate of 24.34%. Profit after tax (PAT) for the same period rose to Rs 24.23 crores, indicating improved profitability. Return on Capital Employed (ROCE) for the half-year stood at 7.30%, the highest recorded in recent periods.

Valuation metrics suggest the stock is trading at a discount relative to its peers. With a ROCE of 4.6 and an enterprise value to capital employed ratio of 0.9, Meghmani Organics presents a very attractive valuation on paper. The company’s profits have increased by 148.2% over the past year, despite the stock’s 24.91% decline in market price. This disparity is reflected in a low PEG ratio of 0.2, indicating that earnings growth has not been matched by share price appreciation.

Sector and Industry Positioning

Operating within the Pesticides & Agrochemicals sector, Meghmani Organics faces a competitive landscape marked by evolving market dynamics. The company’s recent price underperformance relative to sector peers and the broader market underscores the challenges it faces in maintaining investor confidence and market share.

The stock’s current valuation and financial metrics suggest that while the company has demonstrated some operational improvements, these have not translated into sustained market gains. The absence of domestic mutual fund holdings further highlights a cautious stance among institutional investors.

Summary of Key Financial Indicators

To summarise, Meghmani Organics Ltd’s key financial indicators as of early 2026 are as follows:

• New 52-week and all-time low price: Rs.55


• Mojo Score: 32.0 (Mojo Grade: Sell, upgraded from Strong Sell)


• Market Cap Grade: 3


• Operating Profit CAGR (5 years): -18.02%


• Average Return on Equity: 6.03%


• Net Sales (latest six months): Rs 1,190.88 crores, up 24.34%


• Profit After Tax (latest six months): Rs 24.23 crores


• Return on Capital Employed (half-year): 7.30%


• Enterprise Value to Capital Employed: 0.9


• PEG Ratio: 0.2

These figures illustrate a complex picture of a company with improving earnings but persistent market valuation challenges.

Conclusion

Meghmani Organics Ltd’s fall to an all-time low of Rs.55 reflects a prolonged period of underperformance relative to the broader market and its sector. Despite positive recent financial results and attractive valuation metrics, the stock continues to trade below key moving averages and has not attracted significant institutional interest. The company’s long-term earnings contraction and modest profitability ratios contribute to the cautious market sentiment surrounding the stock.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →